Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius Medical Care AG & Co KGaA ST buy geldnutzer

Start price
€75.00
07.11.18 / 50%
Target price
€60.70
04.11.21
Performance (%)
-20.59%
End price
€59.56
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €59.56. The prediction for Fresenius Medical Care AG & Co KGaA ST disappointed with a performance of -20.59%. Dividends of €2.51 are taken into consideration when calculating the performance. geldnutzer has 50% into this prediction

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius Medical Care AG & Co KGaA ST -1.843% -1.843% -10.797% -40.630%
iShares Core DAX® -1.370% -3.231% 11.661% 16.545%
iShares Nasdaq 100 0.172% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.801% -7.859% 18.597% 4.253%
iShares S&P 500 -0.369% -2.979% 26.341% 40.911%

Comments by geldnutzer for this prediction

In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Prediction Buy
Perf. (%) -20.59%
Target price 96.700
Change
Ends at 04.11.21

geldnutzer stimmt dem Sentiment von 'Buy' zu

geldnutzer stimmt am 07.11.2018 dem Buy-Gesamtsentiment mit dem Kursziel 96.7€ zu.

Prediction Buy
Perf. (%) -20.59%
Target price 66.700
Change
Ends at 04.11.21

Kursziel geändert auf 66,7

Prediction Buy
Perf. (%) -20.59%
Target price 76.700
Change
Ends at 04.11.21

Kursziel geändert auf 76,7

Prediction Buy
Perf. (%) -20.59%
Target price 86.700
Change
Ends at 04.11.21

Kursziel geändert auf 86,7

Prediction Buy
Perf. (%) -20.59%
Target price 76.700
Change
Ends at 04.11.21

Kursziel geändert auf 76,7

Prediction Buy
Perf. (%) -20.59%
Target price 79.700
Change
Ends at 04.11.21

Kursziel geändert auf 79,7

Prediction Buy
Perf. (%) -20.59%
Target price 87.700
Change
Ends at 04.11.21

Kursziel geändert auf 87,7

Prediction Buy
Perf. (%) -20.59%
Target price 77.700
Change
Ends at 04.11.21

Kursziel geändert auf 77,7

Prediction Buy
Perf. (%) -20.59%
Target price 70.700
Change
Ends at 04.11.21

Kursziel geändert auf 70,7

Prediction Buy
Perf. (%) -20.59%
Target price 75.700
Change
Ends at 04.11.21

Kursziel geändert auf 75,7

Prediction Buy
Perf. (%) -20.59%
Target price 78.700
Change
Ends at 04.11.21

Kursziel geändert auf 78,7

Prediction Buy
Perf. (%) -20.59%
Target price 68.700
Change
Ends at 04.11.21

Kursziel geändert auf 68,7

Prediction Buy
Perf. (%) -20.59%
Target price 78.700
Change
Ends at 04.11.21

Kursziel geändert auf 78,7

Prediction Buy
Perf. (%) -20.59%
Target price 68.700
Change
Ends at 04.11.21

Kursziel geändert auf 68,7

Prediction Buy
Perf. (%) -20.59%
Target price 60.700
Change
Ends at 04.11.21

Kursziel geändert auf 60,7

In the thread Trading Fresenius Medical Care AG & Co KGaA ST
Prediction Buy
Perf. (%) -20.59%
Target price 60.700
Change
Ends at 04.11.21

Die von geldnutzer gewählte maximale Laufzeit wurde überschritten